NUEL CIPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug NUEL CIPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9505	Tablet	Nectaclav Powder for Oral Suspension (duplicate, different product) PWD_F_SOL 200 mg; 28.5 mg 1 x 100 mL (in glass bottle)	Powder for Suspension A white colored free flowing powder, which on reconstitution becomes off-white colored suspension, having a pleasant flavor 64 CMS-PP-361437 NECTACLAV POWDER FOR ORAL SUSPENSION AMOXICILLIN 200MG, CLAVULANIC ACID 28.5MG/5ML AMOXICILLIN 200MG, CLAVULANIC ACID 28.5MG/5ML (EXCIPIENTS: Syloid 244 FP, Sodium Starch Glycolate, Ac-di-sol, Aerosil (Colloidal Silicon Dioxide), MCC RQ 102, Magnesium Stearate, Ethyl Cellulose, Isopropyl Alcohol, Insta coat solution ICS223 WHITE, Methylene Dichloride, Isopropyl Alcohol, Diethyl Phthalates) A4-9505 Drugs Imported Products 1X100ML POM 1 10/10/2023 NECTAR HEALTHCARE LIMITED, 16B Residence Road, Gbagada Phase 2, Gbagada, Lagos VAPI CARE PHARMA PVT LIMITED, PLOT NO. 225/3 G.I.D.C. NEAR MORARJI CIRCLE, VAPI - 396 195, DIST. VALSAD, GUJARAT, INDIA., India	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9505